A phase 2 study of ibrutinib in combination with bortezomib and dexamethasone in patients with relapsed/refractory multiple myeloma

  1. Hajek, R.
  2. Pour, L.
  3. Ozcan, M.
  4. Martin Sánchez, J.
  5. García Sanz, R.
  6. Anagnostopoulos, A.
  7. Oriol, A.
  8. Cascavilla, N.
  9. Terjung, A.
  10. Lee, Y.
  11. Briso, E.M.
  12. Dobkowska, E.
  13. Hauns, B.
  14. Špička, I.
Revue:
European Journal of Haematology

ISSN: 1600-0609,  0902-4441

Année de publication: 2020

Volumen: 104

Número: 5

Pages: 435-442

Type: Article

DOI: 10.1111/EJH.13377 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus